RegeneRx Biopharmaceuticals, Inc. (RGRX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Feb 12, 2026, 9:30 AM EST

RGRX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Mar '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Cash & Equivalents
0.10.291.230.430.640.24
Cash & Short-Term Investments
0.10.291.230.430.640.24
Cash Growth
-89.02%-76.38%187.83%-33.13%169.71%30.57%
Prepaid Expenses
0.020.010.010.040.030.01
Other Current Assets
-0.010.010.010.010.03
Total Current Assets
0.120.311.250.480.680.27
Property, Plant & Equipment
0.060.070.030.070.020
Other Long-Term Assets
0.010.010.010.010.010.01
Total Assets
0.190.381.280.550.710.28
Accounts Payable
0.040.060.060.040.040.09
Accrued Expenses
0.470.370.260.210.10.09
Current Portion of Long-Term Debt
1.17--0.03-0.05
Current Portion of Leases
0.050.040.030.040.03-
Current Unearned Revenue
0.080.080.080.080.080.08
Total Current Liabilities
1.80.550.430.40.240.32
Long-Term Debt
0.261.371.140.920.71-
Long-Term Leases
0.020.03-0.03--
Long-Term Unearned Revenue
1.851.871.952.022.12.18
Total Liabilities
3.933.833.513.383.052.49
Common Stock
0.140.140.140.130.130.13
Additional Paid-In Capital
108.71108.63108.12105.93104.9103.54
Retained Earnings
-112.6-112.22-110.49-108.89-107.37-105.88
Shareholders' Equity
-3.74-3.45-2.23-2.82-2.34-2.21
Total Liabilities & Equity
0.190.381.280.550.710.28
Total Debt
1.491.451.161.030.740.05
Net Cash (Debt)
-1.39-1.160.07-0.6-0.10.18
Net Cash Per Share
-0.97-0.800.05-0.45-0.070.15
Filing Date Shares Outstanding
1.441.441.441.341.331.3
Total Common Shares Outstanding
1.441.441.441.331.321.28
Working Capital
-1.68-0.250.820.080.44-0.04
Book Value Per Share
-2.61-2.40-1.55-2.12-1.78-1.72
Tangible Book Value
-3.74-3.45-2.23-2.82-2.34-2.21
Tangible Book Value Per Share
-2.61-2.40-1.55-2.12-1.78-1.72
Machinery
-----0.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.